Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
55.78
+0.46 (0.83%)
May 5, 2026, 11:01 AM EDT - Market open
Haemonetics Employees
Haemonetics had 3,023 employees as of March 29, 2025. The number of employees decreased by 634 or -17.34% compared to the previous year.
Employees
3,023
Change (1Y)
-634
Growth (1Y)
-17.34%
Revenue / Employee
$436,082
Profits / Employee
$58,034
Market Cap
2.59B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 29, 2025 | 3,023 | -634 | -17.34% |
| Mar 30, 2024 | 3,657 | 623 | 20.53% |
| Apr 1, 2023 | 3,034 | 213 | 7.55% |
| Apr 2, 2022 | 2,821 | 113 | 4.17% |
| Apr 3, 2021 | 2,708 | -296 | -9.85% |
| Mar 28, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Integer Holdings | 11,000 |
| AdaptHealth | 10,900 |
| LivaNova | 3,300 |
| Neogen | 2,974 |
| iRhythm Holdings | 2,400 |
| Artivion | 1,800 |
| NovoCure | 1,605 |
| Inspire Medical Systems | 1,333 |
HAE News
- 11 days ago - New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures - PRNewsWire
- 4 weeks ago - Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026 - PRNewsWire
- 5 weeks ago - Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System - PRNewsWire
- 2 months ago - Haemonetics Transcript: 47th Annual Raymond James Institutional Investor Conference - Transcripts
- 2 months ago - Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology - PRNewsWire
- 2 months ago - Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference - PRNewsWire
- 3 months ago - These Analysts Revise Their Forecasts On Haemonetics After Q3 Earnings - Benzinga
- 3 months ago - Haemonetics Earnings Call Transcript: Q3 2026 - Transcripts